FDA: Amgen's Anemia Drugs May Cause Death

03/28/2008 02:45 am ET | Updated May 25, 2011
  • Daniel Costello Los Angeles Times

Anemia drugs sold by Amgen Inc. took another hit Thursday when government regulators said two new studies indicated that the drugs may increase the risk of death in some patients.

Based on the studies, the Food and Drug Administration may further restrict the use of the drugs, which already carry the agency's strictest "black box" warning.

"This new information further underscores the safety concerns," said Janet Woodcock, acting director of the FDA's Center for Drug Evaluation and Research. She said the agency "is reviewing these data and may take additional action."